[Heparin or aspirin in the treatment of acute cerebral infarction?].
Zuber
M
M
Service de neurologie, Centre Raymond-Garcin Centre hospitalier Sainte-Anne 75674 Paris. zuber@chsa.broca.inserm.fr
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D002544:Cerebral Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018579:Patient Selection; D012008:Recurrence; D012307:Risk Factors; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D006493:Heparin; D001241:Aspirin